Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) Research & Development (2017 - 2025)

Si-Bone has reported Research & Development over the past 9 years, most recently at $4.4 million for Q4 2025.

  • Quarterly results put Research & Development at $4.4 million for Q4 2025, up 12.74% from a year ago — trailing twelve months through Dec 2025 was $17.4 million (up 5.36% YoY), and the annual figure for FY2025 was $17.4 million, up 5.36%.
  • Research & Development for Q4 2025 was $4.4 million at Si-Bone, up from $4.2 million in the prior quarter.
  • Over the last five years, Research & Development for SIBN hit a ceiling of $4.5 million in Q1 2025 and a floor of $3.0 million in Q1 2021.
  • Median Research & Development over the past 5 years was $3.8 million (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Research & Development: soared 45.45% in 2021 and later fell 8.07% in 2023.
  • Si-Bone's Research & Development stood at $3.0 million in 2021, then grew by 14.14% to $3.5 million in 2022, then grew by 19.6% to $4.2 million in 2023, then fell by 7.02% to $3.9 million in 2024, then grew by 12.74% to $4.4 million in 2025.
  • The last three reported values for Research & Development were $4.4 million (Q4 2025), $4.2 million (Q3 2025), and $4.3 million (Q2 2025) per Business Quant data.